Evidence map›Paper›PMID 35980305›Full record

ArticleJournal of diabetes investigation2022

A survey of clinical physician's perceptions of stigma and advocacy in patients with type 2 diabetes in Kanagawa, Japan.

Yoko Matsuzawa, Kosuke Azuma, Tasuku Sawa, Yoshiaki Ono, Yoshiro Hamada, Ikuro Matsuba, Akira Kanamori

Abstract read
In one paragraph

Article in Journal of diabetes investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. From language matters to stigma-free communication in diabetes: Evolution, challenges, and next steps.Diabetic medicine : a journal of the British Diabetic Association · 2026
    Review
  2. Article
  3. Article
  4. Diabetes advocacy in the Asia-Pacific region.Journal of diabetes investigation · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yoko MatsuzawaThe Study Group of the Medical Communication Committee, Kanagawa Physicians Association, Yokoyama City, Japan.
Kosuke AzumaThe Study Group of the Medical Communication Committee, Kanagawa Physicians Association, Yokoyama City, Japan.
Tasuku SawaThe Study Group of the Medical Communication Committee, Kanagawa Physicians Association, Yokoyama City, Japan.
Yoshiaki OnoThe Study Group of the Medical Communication Committee, Kanagawa Physicians Association, Yokoyama City, Japan.
Yoshiro HamadaThe Study Group of the Medical Communication Committee, Kanagawa Physicians Association, Yokoyama City, Japan.
Ikuro MatsubaThe Study Group of the Medical Communication Committee, Kanagawa Physicians Association, Yokoyama City, Japan.ORCID https://orcid.org/0000-0002-4363-5036
Akira KanamoriThe Study Group of the Medical Communication Committee, Kanagawa Physicians Association, Yokoyama City, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionTo investigate the recognition status of stigma/advocacy in patients with type 2 diabetes in clinical practice settings.

methodA questionnaire survey on stigma/advocacy of patients with diabetes was carried out for members of the Kanagawa Physicians Association in July 2021.

resultsThe respondents consisted of 33 (16.6%) physicians specializing in diabetes (the D group) and 166 (83.4%) non-specialists (the ND group). 100% of the D group and 48.8% of the ND group knew that patients may be prejudiced or discriminated against because of diabetes. In the question of whether they know the terms 'stigma' and 'advocacy', 'know' was 97.0% and 94.0% in the D group, compared with 45.8% and 36.7% in the ND group, respectively. 97.0% of the D group and 19.9% of the ND group know the advocacy activities of the Japanese Diabetes Society (JDS) and the Japan Association for Diabetes Education (JADEC). The specific contents of the stigma were often unknown or never experienced in the ND group. A free description of the strategy for reducing or eliminating stigma was analyzed by text mining. 'Giving consideration to the patients' feelings', 'Commitment to the problem', and 'Dialogue' were frequent, and there was no significant difference between the two groups.

conclusionsThe clinician's understanding of stigma/advocacy associated with having diabetes was insufficient, and activities that alert clinicians to stigma/advocacy, especially those in the ND group, was a theme to be addressed. More awareness-raising activities for stigma/advocacy will lead to better treatment and a better quality of life for patients with diabetes.

Indexed as

Diabetes Mellitus, Type 2PhysiciansHumansJapanQuality of LifeSurveys and QuestionnairesAdvocacyClassified stigmasStigma

Identifiers

PMID35980305
PMCPMC9720217

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.